Agir Hakan, Aburn Neil, Davis Charles, MacKinnon Craig, Tan Swee T
Head & Neck and Skull Base Surgery/Oncology Programme, Wellington Regional Plastic, Maxillofacial & Burns Unit, Hutt Hospital, Wellington, New Zealand.
J Craniofac Surg. 2007 Sep;18(5):1148-53. doi: 10.1097/scs.0b013e31814510bb.
Orbital pseudotumor is a nonspecific, idiopathic benign inflammatory process characterized by a polymorphous lymphoid infiltrate with varying degrees of fibrosis. We retrospectively reviewed the clinical presentation, management, and progress of six consecutive patients referred to our service with an initial diagnosis of orbital pseudotumor to underscore the challenge and pitfalls in managing this group of patients. Three male and three female patients, aged 27 to 74 years, presented with a variety of ophthalmologic problems, including orbital swelling, chemosis, proptosis, blepharoptosis, restricted eye motion, diplopia, and visual loss. The initial diagnosis of orbital pseudotumor was based on clinical findings, results of routine laboratory screening tests, computed tomographic and/or magnetic resonance imaging scans, and the response to corticosteroid treatment in three patients. In these three patients, the final diagnosis of orbital pseudotumor was confidently made only in one patient who remained in remission after corticosteroid therapy. The remaining two patients had Miller-Fisher syndrome and thyroid ophthalmopathy. Three other patients initially diagnosed with orbital pseudotumor underwent biopsy through an orbitotomy with comprehensive histopathologic evaluation. Two of these patients were subsequently diagnosed with non-Hodgkin lymphoma. Orbital pseudotumor belongs to a spectrum of lymphocytic infiltrative orbital conditions. It is a diagnosis of exclusion. The initial diagnosis must be regarded as provisional, and failure of complete resolution with corticosteroid therapy should heighten the index of suspicion and a biopsy should be considered. However, diagnosis may be difficult even with comprehensive histopathologic studies.
眼眶假瘤是一种非特异性、特发性良性炎症过程,其特征为多形性淋巴细胞浸润并伴有不同程度的纤维化。我们回顾性分析了连续6例最初诊断为眼眶假瘤并转诊至我院的患者的临床表现、治疗及病情进展,以强调管理这类患者所面临的挑战和陷阱。3例男性和3例女性患者,年龄27至74岁,表现出多种眼科问题,包括眼眶肿胀、结膜水肿、眼球突出、上睑下垂、眼球运动受限、复视和视力丧失。眼眶假瘤的初步诊断基于临床表现、常规实验室筛查结果、计算机断层扫描和/或磁共振成像扫描,以及3例患者对皮质类固醇治疗的反应。在这3例患者中,仅1例在皮质类固醇治疗后病情缓解,从而确诊为眼眶假瘤。其余2例患者分别患有米勒-费雪综合征和甲状腺眼病。另外3例最初诊断为眼眶假瘤的患者通过眼眶切开术进行活检并进行了全面的组织病理学评估。其中2例患者随后被诊断为非霍奇金淋巴瘤。眼眶假瘤属于淋巴细胞浸润性眼眶疾病的范畴。它是一种排除性诊断。初始诊断必须视为临时诊断,皮质类固醇治疗后未能完全缓解应提高怀疑指数并考虑进行活检。然而,即使进行全面的组织病理学研究,诊断也可能困难。